Clinical trial
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver…
NCT00185874 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00185874 |
|---|---|
| Title | Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases |
| Official title | A Phase I Trial of Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Biological |
| Interventions | Intratumoral Dendritic Cell Immunotherapy, autologous dendritic cells |
| Enrollment | 22 |
| Start date | Jan 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: